CANBERRA, Feb. 4 (Xinhua) -- Researchers in Australia have discovered a rare genetic mutation that could explain why some people do not respond to newer schizophrenia treatments. The study, published in Genomic Psychiatry, reveals that an inherited change in the brain can completely block the function of the trace amine-associated receptor 1 (TAAR1), a receptor targeted by newer schizophrenia drugs making them i
